Approximately 89,507 vials of Acetylcysteine for Injection (6 g/30 mL) have been recalled due to deviations from Current Good Manufacturing Practice (CGMP) standards. This prescription drug is used to treat paracetamol (acetaminophen) overdoses and to thin mucus in patients with certain lung conditions. While no specific injuries were reported in the data, the manufacturing issues may compromise the quality and safety of the medication. Consumers should verify if their medication matches the affected lot numbers and contact their healthcare provider immediately for instructions.
The recall was initiated due to manufacturing process failures (CGMP deviations) which could result in a product that does not meet safety or quality specifications. For an injectable medication, these deviations could lead to potential contamination or incorrect dosing, posing a moderate risk to patients requiring emergency treatment for overdoses or respiratory distress.
Healthcare provider consultation and pharmacy refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.